ReviewInternational journal of emergency medicine2025
Visualizing the landscape of ocular melanoma research: a bibliometric analysis.
Review in International journal of emergency medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Toward Precision Medicine: Gene Therapy Applications in the Management of Uveal Melanoma.Cancer reports (Hoboken, N.J.) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionOcular melanoma is a type of malignancy affecting the eye. Symptoms can include dark spots near or around the iris or the mucous membrane of the eyes. Treatments include radiation, laser therapy, and enucleation or evisceration of the eye.
methodA bibliometric analysis was conducted using the database Web of Science. VosViewer version 1.6.20 was utilized to import tab-delimited files and visualize the data from Web of Science.
resultsData was collected from 1990 to 2024, with 2021 being the highest publication year (258). The U.S. (1,950), Germany (405), and England (205) released the greatest number of publications. From those countries, Thomas Jefferson University and Leiden University released the largest number of articles written about ocular melanoma.
conclusionOcular melanoma is a rare type of cancer affecting people worldwide. As medicinal research advances over time, the ability to prevent and treat ocular melanoma steadily improves. Over the past years (1990-2024), there has been a general increase in the number of publications regarding ocular melanoma. There have been gaps in the research in South Asian and African demographics, showing that these communities have not brought enough attention to this disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.